Lung Diseases, Interstitial D017563

Diseases [C] » Respiratory Tract Diseases [C08] » Lung Diseases » Lung Diseases, Interstitial

Description

A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.   MeSH

Subtype Terms (8)

Alveolitis, Extrinsic Allergic
8 drugs (6 approved, 2 experimental)

Anti-Glomerular Basement Membrane Disease
1 experimental drug

Granulomatosis with Polyangiitis
30 drugs (25 approved, 5 experimental)

Histiocytosis, Langerhans-Cell
54 drugs (43 approved, 11 experimental)

Pneumoconiosis
1 experimental drug

Pulmonary Fibrosis
44 drugs (30 approved, 14 experimental)

Radiation Pneumonitis
19 drugs (13 approved, 6 experimental)

Sarcoidosis, Pulmonary
27 drugs (19 approved, 8 experimental)



Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.